Can Blood Gas Enhance Early Warning Systems by streamlining ICU Transfer Decisions: A Qualitative Systematic Review

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Importance

Delay in transfer to Intensive Care Unit (ICU) is associated with known adverse clinical and economic outcomes. There are several early warning systems (EWS) that help identify patients that could benefit from earlier ICU transfer but are fraught with challenges when used to measure delays. An objective time stamped blood test metric, such as a blood gas, could be a valuable adjunct in identifying patients and measuring delays in who require intrahospital transfer to the ICU.

Background

Delays in transferring critically ill patients to the intensive care unit (ICU) are linked to increased mortality, organ failure, prolonged recovery, and higher hospital costs. While Early Warning Scoring (EWS) systems like MEWS, NEWS2, and eCART aim to detect deterioration using vital signs and medical data, they often rely on intermittent and/or subjective inputs. Despite advances, including AI-driven models, most systems still lack accuracy to detect and quantify transfer delays, an important operational metric.

Objective

This review explores the clinical and operational impact of ICU transfer delays and evaluates the potential role of blood gas analyses (ABG) analysis as an objective, time-stamped adjunct biomarker for early identification of high-risk patients. We also assess whether ABG could be integrated into EWS tools to enhance predictive accuracy.

Methods

We conducted a systematic literature review of studies published between 1994 and 2024 using PubMed, EMBASE, Cochrane, and NIH databases. Inclusion criteria focused on studies that examined ICU transfer delays, ABG parameters (e.g., lactate, pH, base excess), and clinical outcomes in adult or pediatric patients. Studies were excluded if they had small sample sizes (n < 50), lacked outcome data, or were not published in English.

Results

The review found that delays in ICU transfer are consistently linked to worse clinical outcomes and higher healthcare costs. While EWS tools have improved early recognition of patient deterioration, they still lack objective, time-stamped markers to measure delays. Approximately one-third of the included studies specifically examined ABG parameters in relation to ICU transfer or outcomes. Elevated lactate levels and abnormal pH values correlated with increased ICU admission, adverse prognosis and mortality risk. Despite this, ABG is not currently integrated into most clinical decision-making tools used for ICU triage.

Conclusion

ABG analysis represents a promising, underutilized tool that could fill a critical gap in current ICU triage systems. As a time-stamped, objective measure of physiological instability, ABG could enhance the accuracy, timeliness and measurability of ICU transfer decisions—especially when combined with electronic medical records and modern EWS platforms. Future research should focus on evaluating ABG as a predictive input within next-generation EWS tools, with the goal of reducing ICU transfer delays, improving patient outcomes, and optimizing hospital resource use.

Article activity feed